Vegfa protects the glomerular microvasculature in diabetes. - Wikidata - awgldk - TriplyDB

Vegfa protects the glomerular microvasculature in diabetes.

Vegfa protects the glomerular microvasculature in diabetes.

http://www.wikidata.org/entity/Q36339615

about

Anthocyanin-rich purple corn extract inhibit diabetes-associated glomerular angiogenesis Insulin receptor substrate-2 is expressed in kidney epithelium and up-regulated in diabetic nephropathy Renal endothelial dysfunction in diabetic nephropathy Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy Crosstalk in glomerular injury and repair Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy Yi qi qing re gao attenuates podocyte injury and inhibits vascular endothelial growth factor overexpression in puromycin aminonucleoside rat model.Podocytes, signaling pathways, and vascular factors in diabetic kidney disease Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.Reduced Krüppel-like factor 2 expression may aggravate the endothelial injury of diabetic nephropathy.Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell Anemia.Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.Vascular complications of diabetes: mechanisms of injury and protective factors Simultaneous pancreas-kidney transplantation in patients with type 1 diabetes reverses elevated MBL levels in association with MBL2 genotype and VEGF expression.Role of the eNOS-NO system in regulating the antiproteinuric effects of VEGF receptor 2 inhibition in diabetes.VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level.Endothelial-podocyte crosstalk: the missing link between endothelial dysfunction and albuminuria in diabetes.Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice.Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy.The endothelium in diabetic nephropathy.Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease.Small Vessels, Big Role: Renal Microcirculation and Progression of Renal Injury.The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes.Antiangiogenic Therapy for Diabetic Nephropathy.Insulin directly stimulates VEGF-A production in the glomerular podocyte VEGF-A165 b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF-A splice isoforms from the kidney.Human umbilical cord Wharton jelly cells promote extra-pancreatic insulin formation and repair of renal damage in STZ-induced diabetic mice.Molecular Mechanisms and Treatment Strategies in Diabetic Nephropathy: New Avenues for Calcium Dobesilate-Free Radical Scavenger and Growth Factor Inhibition The vasculature in diabetic nephropathy: all tied up?Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.Novel avenues for drug discovery in diabetic kidney disease.Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology.Heparan sulfate 6-O-endosulfatases, Sulf1 and Sulf2, regulate glomerular integrity by modulating growth factor signaling.Acute Kidney Injury and Progression of Diabetic Kidney Disease.Modified scanning electron microscopy reveals pathological crosstalk between endothelial cells and podocytes in a murine model of membranoproliferative glomerulonephritis.

P2860

Q21132429-C5A06C4C-CA12-4D61-9785-82449DACD17C Q24338974-5BB2B2AF-00D4-47BA-A651-01DF9834AEE0 Q27021318-E3C4FC09-5188-415B-A0FE-52383B2CFE4D Q27342809-94164D61-2901-4436-8BBE-ED7B83202F07 Q28085092-4E77D439-C9D0-4603-9F1F-AB8F1252053B Q28354224-5FD2AA1F-8B1C-47FD-AA56-1AD5CC6FE9CD Q33748334-9D41FE86-9D5B-4D1E-8380-7BEBCF421D3A Q33821237-7B912724-BF2C-472A-AE30-40BDB7AE68AD Q34257934-0F6B0159-20BB-4AC6-9106-5EE7449A02AE Q35033762-24459943-6DF3-4C9C-859B-355850AD5584 Q35434381-5E421ED2-6506-40F5-A30E-2B9AA4E207EB Q36144830-BB7094C9-5F48-4055-99A8-CF3AE69EEA42 Q36297539-6C22B55B-D66D-4E25-9FDD-9C0CA158C5F7 Q36537262-44CC1AE1-531E-42C5-896C-860A0D2B8DA0 Q36653992-9266214A-F55C-4436-B531-0A4BA7BABB0E Q37154812-94C90D2F-750B-4D8F-BB5B-A9FC0ADC8EC9 Q37197773-B2417DE3-1414-4007-85F9-C83BF29D637C Q37251105-7D9E48DD-B61C-4158-BC9C-C247D01834E3 Q37403354-AAAE0430-40E2-40D3-ADFD-77BD3D69AE25 Q38175408-60EF8BAE-4F96-4788-8337-2E9135B0DD58 Q38195528-D240ED6D-E1B8-4515-856D-5221DB1288B5 Q38332511-B03AE93F-D585-40BC-92DD-8BE3E40F342F Q38883369-0D20CFFB-5DC7-4291-863C-AD471F0871C6 Q39134052-20A665F0-6CE2-4B58-BCCE-ED9D59BB6258 Q41354182-72C82F01-954B-4CA8-B5AC-A6BC782C082B Q41403094-13935EE0-1035-4A7C-B453-85ED3612C8AA Q41827044-E9747205-BFB5-4562-B411-BCF53D726D7E Q42367439-60C56C6F-8EDC-4406-A530-76C8839DD028 Q42657769-793BA50B-AB1D-40AA-8936-BB5B0A0846CC Q42706693-74F42A2A-77DE-4C45-8162-F4FF59F5257D Q42778043-9341EA7B-C85C-47FA-A215-A69E3CF05B6F Q42778066-06488545-271D-41E0-BCFC-143174421314 Q45072634-C4EEDA6F-4A58-4B15-B97C-A71CEF6156D2 Q47395215-9FB4264C-147A-4CFD-A36A-3A3AEBC3A13B Q47836465-D394C929-628F-4941-B2C4-47153A31C079 Q52667051-AEAAE77E-AA55-423C-A923-0E4A50D93E78 Q52724019-E960AA4E-32FE-408D-9DA2-FAE6D4C43D08 Q55709365-E42D4109-7B51-493F-B46D-F002968DD7FB

P2860

Vegfa protects the glomerular microvasculature in diabetes.

http://www.wikidata.org/entity/Q36339615

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Vegfa protects the glomerular microvasculature in diabetes.

@ast

Vegfa protects the glomerular microvasculature in diabetes.

@en

type

label

Vegfa protects the glomerular microvasculature in diabetes.

@ast

Vegfa protects the glomerular microvasculature in diabetes.

@en

prefLabel

Vegfa protects the glomerular microvasculature in diabetes.

@ast

Vegfa protects the glomerular microvasculature in diabetes.

@en

P1433

Q36339615-BDA7DDE5-FD09-46CE-B0BD-68BCCA88F4DC

P1476

Q36339615-F0EAB4F4-B9CF-47A6-9ABC-BCD1438D90BA

P2093

Q36339615-28803BFF-7CD6-4626-B88D-52F2D278B006

Q36339615-8E31B8F7-5A4B-4337-88DF-C8B3DC79C139

Q36339615-A491ACE8-C89F-4F4E-A423-477061B2A71E

Q36339615-E8A8C344-7317-4E4C-9C26-550C0F525FBD

P2860

Q36339615-019610F7-231E-4401-A147-F680527A38C2

Q36339615-176BE642-D9CB-4772-8541-692A7836F591

Q36339615-17A0DC14-0F27-4BBD-A68F-5BB0FDB85EE1

Q36339615-1AB7FF80-7914-473C-8D9A-28F412FCF892

Q36339615-1C5AEFC1-77B5-4EA9-BB69-378F37B3C196

Q36339615-21788647-7AFC-477B-88CE-059DADF1DD4E

Q36339615-25005E78-892B-4192-B22B-447457BB3E3A

Q36339615-2CEFA75D-E3C6-4224-9147-83A69A30A5D4

Q36339615-2DF3A514-C36A-426F-8D91-5B22C7222F4A

Q36339615-369B47A4-9EB8-472D-B791-2AC899478B33

P304

Q36339615-88A880BC-080F-4843-A905-0E597844E732

P31

Q36339615-F5BEB5F4-9D6D-48AE-8BFB-1B3DF8C681B6

P356

Q36339615-CF9E69C9-E762-46EE-AFD6-E9ED4159686F

P407

Q36339615-A8FD60B9-4F6B-4FC7-BC88-70D7A617A180

P433

Q36339615-DF6A8E14-FF8B-452C-A1DD-DE735A1850A5

P478

Q36339615-A3D3CE90-87A2-4D1E-8FDA-A5CC7823828B

P50

Q36339615-29BCF967-E3B7-405D-8B26-70BB1DB50BC6

Q36339615-C4A80830-D2AD-4AD6-A922-48A7335C5312

P577

Q36339615-C4F590C9-8BA7-4B6C-81D2-4D37F3402CD4

P5875

Q36339615-5B0E8832-1E72-44CF-851A-26EB07575210

P698

Q36339615-C49E05BE-2F40-4051-8292-D6CBB715225A

P932

Q36339615-8266EB89-7D48-42F9-968D-315F7F600FC8

P356

P1433

P1476

Vegfa protects the glomerular microvasculature in diabetes

@en

P2093

Gavasker A Sivaskandarajah

http://www.w3.org/2001/XMLSchema#string

Susan E Quaggin

http://www.w3.org/2001/XMLSchema#string

Vera Eremina

http://www.w3.org/2001/XMLSchema#string

Yoshiro Maezawa

http://www.w3.org/2001/XMLSchema#string

P2860

Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.

VEGF inhibition and renal thrombotic microangiopathy

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis

Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.

Caspases and calpain are independent mediators of cisplatin-induced endothelial cell necrosis.

Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.

Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma.

Mouse models of diabetic nephropathy.

P304

2958-2966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB11-1655

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232649128

http://www.w3.org/2001/XMLSchema#string

P698

23093658

http://www.w3.org/2001/XMLSchema#string

P932

3478549

http://www.w3.org/2001/XMLSchema#string